Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study
Articles > Article ยท 2017
Authors: Alessandra Franzetti Pellanda, Berardino De Bari, Elisabeth Deniaud-Alexandre, Marco Krengli, Paul Van Houtte, Antonella Richetti, Salvador Villa, Hadassah Goldberg, Ewa Szutowicz-Zielinska, Michel Bolla, Heidi Rutten, Marc Van Eijkeren, Philip Poortmans, Guido Henke, Yavuz ANACAK, Steve Chan, Christine Landmann, Carine Kirkove, Luciano Scandolaro, Jacques Bernier, Rene-Olivier Mirimanoff, Mahmut Ozsahin
CHINESE JOURNAL OF CANCER RESEARCH, Journal Indexed in SCI Expanded, International, 2017, vol 29, pp 521-532
DOI: 10.21147/j.issn.1000-9604.2017.06.06
Summary
Objective: Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.